Hair loss in normal conditions is to be considered a natural physiological process of hair replacement. Hair growth, loss and regrowth are part of the hair life cycle, a sequence that is repeated continuously throughout a person’s life.
As long as hair loss is within the confines of this regrowth cycle it needn’t worry. However, when the phenomenon is triggered by exogenous, genetic or hormonal factors, it is possible that the falling structures are not adequately replaced by equally healthy hair.
Depending on the characteristics of the person and other factors such as problems with the scalp or the hair bulb, hair loss can manifest itself in many different forms. Baldness, or androgenetic alopecia, is the most common hair problem. More than 70% of men and 40% of women are affected in their lifetime.
The new Crescina Transdermic Follicular Islands Rapid-Intensive combines in a single vial the two treatments PLC12 and Bulge-Stem, with the technological innovation of the new Scalp Microbiome Complex and 3+2 enhancers.
The PLC12 treatment (Swiss Patent CH 713 030) contains the complex of 12 Plate-Like molecules which, being synthetic substances similar to the endogenous peptide molecules naturally present in the hair system, are designed to physiologically and synergistically promote hair growth.
Fundamental to intensify the activity of the components is the optimal condition of the microbiome of the scalp, on which acts the new Scalp Microbiome Complex, consisting of Sarcosine (prebiotic, able to increase the colonization of the scalp by beneficial strains by reducing the level of sebum), and Pseudoalteromonas Ferment Extract (postbiotic, reduces microinflammation of the scalp by counteracting the follicular miniaturization).
All the active molecules of the two treatments have been subjected to transdermal penetration tests with Franz Cells.